Transaction #18423 · Form 4 · 0001193125-25-316180
Dolby Laboratories, Inc. · Exercise / conversion · Class A Common Stock
Dolby Laboratories, Inc. · Transacted December 9, 2025 · Filed December 11, 2025
What does this filing report?
An SEC Form 4 filing for Dolby Laboratories, Inc. records an exercise / conversion involving Class A Common Stock on December 9, 2025. The reported quantity was 10,615. The filing date is December 11, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Dolby Laboratories, Inc.
- Company CIK
- 0001308547
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 10,615
- Reported price
- 64.6
- Reference value
- 685,729
- Currency
- Currency not specified
- Ownership
- Indirect
- Holdings after transaction
- 108,992
- Ownership description
- By a trust
- SEC acceptance time
- Dec 11, 2025, 5:04 PM EST
- 10b5-1 indication
- Indicated in filing
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- YEAMAN KEVIN J ↗
President and CEO · Director
CIK 0001200469
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Filing footnotes & remarks
- F1
- By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009
- F2
- The shares were sold in multiple transactions at prices ranging from $66.38 to $67.37, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- F3
- The shares were sold in multiple transactions at prices ranging from $67.39 to $67.60, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- F4
- Shares held following the reported transactions include 127,735 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
- F5
- This option was granted for a total of 194,399 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date.
- F6
- This performance-based stock option award was granted for a total of 82,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 17, 2021 was at 75% of target, or 61,500 shares.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.